Recombinant viral veterinary vaccinesFunded under: FP2-BRIDGE
Within the framework of the Community's biotechnology research programmes, groups of contractors were brought together to constitute ELWWs, with a view to facilitating the rapid circulation and exchange of information, data and materials, and increasing mobility among research staff. The purpose of this brochure is to illustrate the work of one such ELWW in the field of recombinant viral veterinary vaccines. The subject of vaccination is discussed in general terms and the participants and areas of research in this particular project are then presented. The main objectives of the research were: (i) the development of second generation vaccines against parvoviruses; (ii) engineering and immunogenicity of foot-and-mouth disease virus procapsids produced in insect cells; (iii) to study the avian herpesvirus genome of Marek's disease virus; (iv) to develop a second generation vaccine against bovine herpesvirus type 1: immunological characterisation of herpesviral glycoproteins and construction of BHV1 deletion mutants. Progress in these areas is reported and the benefits of the collaboration are discussed. A glossary of terms is also provided.
Bibliographic Reference: Report: EN (1992) 19 pp.
Availability: Available from the BRIDGE Programme Office, CEC, DG XII, 200 rue de la Loi, B-1049 Bruxelles (BE)
Record Number: 199330022 / Last updated on: 1994-11-29
Original language: en
Available languages: en